388 related articles for article (PubMed ID: 21400563)
1. Alternative splicing dysregulation secondary to skeletal muscle regeneration.
Orengo JP; Ward AJ; Cooper TA
Ann Neurol; 2011 Apr; 69(4):681-90. PubMed ID: 21400563
[TBL] [Abstract][Full Text] [Related]
2. CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1.
Ward AJ; Rimer M; Killian JM; Dowling JJ; Cooper TA
Hum Mol Genet; 2010 Sep; 19(18):3614-22. PubMed ID: 20603324
[TBL] [Abstract][Full Text] [Related]
3. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
[TBL] [Abstract][Full Text] [Related]
4. The hallmarks of myotonic dystrophy type 1 muscle dysfunction.
Ozimski LL; Sabater-Arcis M; Bargiela A; Artero R
Biol Rev Camb Philos Soc; 2021 Apr; 96(2):716-730. PubMed ID: 33269537
[TBL] [Abstract][Full Text] [Related]
5. Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.
Tang ZZ; Yarotskyy V; Wei L; Sobczak K; Nakamori M; Eichinger K; Moxley RT; Dirksen RT; Thornton CA
Hum Mol Genet; 2012 Mar; 21(6):1312-24. PubMed ID: 22140091
[TBL] [Abstract][Full Text] [Related]
6. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S
Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519
[TBL] [Abstract][Full Text] [Related]
7. Highly efficient in vivo delivery of PMO into regenerating myotubes and rescue in laminin-α2 chain-null congenital muscular dystrophy mice.
Aoki Y; Nagata T; Yokota T; Nakamura A; Wood MJ; Partridge T; Takeda S
Hum Mol Genet; 2013 Dec; 22(24):4914-28. PubMed ID: 23882132
[TBL] [Abstract][Full Text] [Related]
8. HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy.
Li M; Zhuang Y; Batra R; Thomas JD; Li M; Nutter CA; Scotti MM; Carter HA; Wang ZJ; Huang XS; Pu CQ; Swanson MS; Xie W
Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5472-5477. PubMed ID: 32086392
[TBL] [Abstract][Full Text] [Related]
9. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
Dansithong W; Paul S; Comai L; Reddy S
J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
[TBL] [Abstract][Full Text] [Related]
10. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
[TBL] [Abstract][Full Text] [Related]
11. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.
Lin X; Miller JW; Mankodi A; Kanadia RN; Yuan Y; Moxley RT; Swanson MS; Thornton CA
Hum Mol Genet; 2006 Jul; 15(13):2087-97. PubMed ID: 16717059
[TBL] [Abstract][Full Text] [Related]
12. Calcitriol increases MBNL1 expression and alleviates myotonic dystrophy phenotypes in HSA
Huang K; Wang DD; Hu WB; Zeng WQ; Xu X; Li QX; Bi FF; Yang H; Qiu J
J Transl Med; 2022 Dec; 20(1):588. PubMed ID: 36510245
[TBL] [Abstract][Full Text] [Related]
13. Studying the Effect of MBNL1 and MBNL2 Loss in Skeletal Muscle Regeneration.
Yadava RS; Mandal M; Mahadevan MS
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473933
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the effects of CELF1 deficiency in a mouse model of RNA toxicity.
Kim YK; Mandal M; Yadava RS; Paillard L; Mahadevan MS
Hum Mol Genet; 2014 Jan; 23(2):293-302. PubMed ID: 24001600
[TBL] [Abstract][Full Text] [Related]
15. Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain.
Suenaga K; Lee KY; Nakamori M; Tatsumi Y; Takahashi MP; Fujimura H; Jinnai K; Yoshikawa H; Du H; Ares M; Swanson MS; Kimura T
PLoS One; 2012; 7(3):e33218. PubMed ID: 22427994
[TBL] [Abstract][Full Text] [Related]
16. Distribution of alternative untranslated regions within the mRNA of the CELF1 splicing factor affects its expression.
Kajdasz A; Niewiadomska D; Sekrecki M; Sobczak K
Sci Rep; 2022 Jan; 12(1):190. PubMed ID: 34996980
[TBL] [Abstract][Full Text] [Related]
17. Reexpression of pyruvate kinase M2 in type 1 myofibers correlates with altered glucose metabolism in myotonic dystrophy.
Gao Z; Cooper TA
Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13570-5. PubMed ID: 23901116
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features.
Dansithong W; Wolf CM; Sarkar P; Paul S; Chiang A; Holt I; Morris GE; Branco D; Sherwood MC; Comai L; Berul CI; Reddy S
PLoS One; 2008; 3(12):e3968. PubMed ID: 19092997
[TBL] [Abstract][Full Text] [Related]
19. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
20. ABLIM1 splicing is abnormal in skeletal muscle of patients with DM1 and regulated by MBNL, CELF and PTBP1.
Ohsawa N; Koebis M; Mitsuhashi H; Nishino I; Ishiura S
Genes Cells; 2015 Feb; 20(2):121-34. PubMed ID: 25403273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]